These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17885584)

  • 1. Computational model predicts effective delivery of 188-Re-labeled melanin-binding antibody to metastatic melanoma tumors with wide range of melanin concentrations.
    Schweitzer AD; Rakesh V; Revskaya E; Datta A; Casadevall A; Dadachova E
    Melanoma Res; 2007 Oct; 17(5):291-303. PubMed ID: 17885584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.
    Revskaya E; Jongco AM; Sellers RS; Howell RC; Koba W; Guimaraes AJ; Nosanchuk JD; Casadevall A; Dadachova E
    Clin Cancer Res; 2009 Apr; 15(7):2373-9. PubMed ID: 19293257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phage display library derived peptides that bind to human tumor melanin as potential vehicles for targeted radionuclide therapy of metastatic melanoma.
    Howell RC; Revskaya E; Pazo V; Nosanchuk JD; Casadevall A; Dadachova E
    Bioconjug Chem; 2007; 18(6):1739-48. PubMed ID: 17907769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma stem cells in experimental melanoma are killed by radioimmunotherapy.
    Jandl T; Revskaya E; Jiang Z; Harris M; Dorokhova O; Tsukrov D; Casadevall A; Dadachova E
    Nucl Med Biol; 2013 Feb; 40(2):177-81. PubMed ID: 23146306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement-dependent cytotoxicity of an antibody to melanin in radioimmunotherapy of metastatic melanoma.
    Jandl T; Revskaya E; Jiang Z; Bryan RA; Casadevall A; Dadachova E
    Immunotherapy; 2013 Apr; 5(4):357-64. PubMed ID: 23557419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-clinical evaluation and efficacy studies of a melanin-binding IgM antibody labeled with 188Re against experimental human metastatic melanoma in nude mice.
    Dadachova E; Revskaya E; Sesay MA; Damania H; Boucher R; Sellers RS; Howell RC; Burns L; Thornton GB; Natarajan A; Mirick GR; DeNardo SJ; DeNardo GL; Casadevall A
    Cancer Biol Ther; 2008 Jul; 7(7):1116-27. PubMed ID: 18535406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, dosimetry and toxicity of rhenium-188-labeled anti-carcinoembryonic antigen monoclonal antibody, MN-14, in gastrointestinal cancer.
    Juweid M; Sharkey RM; Swayne LC; Griffiths GL; Dunn R; Goldenberg DM
    J Nucl Med; 1998 Jan; 39(1):34-42. PubMed ID: 9443735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma.
    Börjesson PK; Postema EJ; Roos JC; Colnot DR; Marres HA; van Schie MH; Stehle G; de Bree R; Snow GB; Oyen WJ; van Dongen GA
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3961S-72S. PubMed ID: 14506195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
    Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 166Ho and 90Y labeled 6D2 monoclonal antibody for targeted radiotherapy of melanoma: comparison with 188Re radiolabel.
    Thompson S; Ballard B; Jiang Z; Revskaya E; Sisay N; Miller WH; Cutler CS; Dadachova E; Francesconi LC
    Nucl Med Biol; 2014 Mar; 41(3):276-81. PubMed ID: 24533987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors.
    Sung C; Shockley TR; Morrison PF; Dvorak HF; Yarmush ML; Dedrick RL
    Cancer Res; 1992 Jan; 52(2):377-84. PubMed ID: 1728409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels.
    Shockley TR; Lin K; Sung C; Nagy JA; Tompkins RG; Dedrick RL; Dvorak HF; Yarmush ML
    Cancer Res; 1992 Jan; 52(2):357-66. PubMed ID: 1728407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dead cells in melanoma tumors provide abundant antigen for targeted delivery of ionizing radiation by a mAb to melanin.
    Dadachova E; Nosanchuk JD; Shi L; Schweitzer AD; Frenkel A; Nosanchuk JS; Casadevall A
    Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14865-70. PubMed ID: 15469923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics.
    van Gog FB; Visser GW; Klok R; van der Schors R; Snow GB; van Dongen GA
    J Nucl Med; 1996 Feb; 37(2):352-62. PubMed ID: 8667076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies.
    Gestin JF; Loussouarn A; Bardiès M; Gautherot E; Gruaz-Guyon A; Saï-Maurel C; Barbet J; Curtet C; Chatal JF; Faivre-Chauvet A
    J Nucl Med; 2001 Jan; 42(1):146-53. PubMed ID: 11197965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabeled melanin-binding peptides are safe and effective in treatment of human pigmented melanoma in a mouse model of disease.
    Dadachova E; Moadel T; Schweitzer AD; Bryan RA; Zhang T; Mints L; Revskaya E; Huang X; Ortiz G; Nosanchuk JS; Nosanchuk JD; Casadevall A
    Cancer Biother Radiopharm; 2006 Apr; 21(2):117-29. PubMed ID: 16706632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer.
    Postema EJ; Börjesson PK; Buijs WC; Roos JC; Marres HA; Boerman OC; de Bree R; Lang M; Munzert G; van Dongen GA; Oyen WJ
    J Nucl Med; 2003 Oct; 44(10):1690-9. PubMed ID: 14530488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose rhenium-186-labeling of monoclonal antibodies for clinical application: pitfalls and solutions.
    van Gog FB; Visser GW; Stroomer JW; Roos JC; Snow GB; van Dongen GA
    Cancer; 1997 Dec; 80(12 Suppl):2360-70. PubMed ID: 9406684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of systemic radiotherapy with I-131-labeled monoclonal antibody BW575/9 to external beam radiotherapy in human neuroblastoma xenografts.
    Sautter-Bihl ML; Wessely R; Bihl H
    Strahlenther Onkol; 1993 Oct; 169(10):595-600. PubMed ID: 8235984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes.
    Dadachova E; Howell RW; Bryan RA; Frenkel A; Nosanchuk JD; Casadevall A
    J Nucl Med; 2004 Feb; 45(2):313-20. PubMed ID: 14960655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.